JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6126
Nuveen Variable Rate Preferred & Income Fund
NPFD
$426M
| $11K | ﹤0.01% |
+676
| New | +$10.6K |
2023 Q4
0 quarters
|
|
6127
BlackRock Floating Rate Income Trust
BGT
$312M
| $11K | ﹤0.01% |
885
+26
| +3% | +$311 |
2023 Q2
2 quarters
|
|
6128
Odyssey Marine Exploration
OMEX
$40.5M
| $11K | ﹤0.01% |
2,355
+2,332
| +10,139% | +$8.49K |
2023 Q3
1 quarter
|
|
6129
ProShares Ultra QQQ
QLD
$15.1B
| $10.9K | ﹤0.01% |
288
-154
| -35% | -$5.08K |
2023 Q2
2 quarters
|
|
6130
PUT
3M
MMM
$84.1B
| $10.9K | ﹤0.01% |
120
-21,528
| -99% | -$1.73M |
2016 Q2
30 quarters
|
|
|
ONCT
6131
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $10.8K | ﹤0.01% |
1,004
| – | – |
2020 Q2
14 quarters
|
|
|
TSBX
6132
DELISTED
Turnstone Biologics
TSBX
| $10.7K | ﹤0.01% |
4,222
| – | – |
2023 Q3
1 quarter
|
|
|
FNCB
6133
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $10.6K | ﹤0.01% |
+1,567
| New | +$9.56K |
2023 Q4
0 quarters
|
|
|
VCSA
6134
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $10.6K | ﹤0.01% |
1,295
-178
| -12% | -$1.44K |
2022 Q2
6 quarters
|
|
6135
Invesco CEF Income Composite ETF
PCEF
$771M
| $10.6K | ﹤0.01% |
591
+314
| +113% | +$5.4K |
2015 Q4
32 quarters
|
|
6136
Global Indemnity Group
GBLI
$361M
| $10.5K | ﹤0.01% |
326
-211
| -39% | -$7.04K |
2013 Q2
42 quarters
|
|
|
ETB
6137
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$451M
| $10.4K | ﹤0.01% |
800
| – | – |
2023 Q2
2 quarters
|
|
6138
SELLAS Life Sciences
SLS
$2.29B
| $10.4K | ﹤0.01% |
9,793
+5,759
| +143% | +$6.23K |
2023 Q2
2 quarters
|
|
|
PDX
6139
PIMCO Dynamic Income Strategy Fund
PDX
$916M
| $10.2K | ﹤0.01% |
500
| – | – |
2023 Q3
1 quarter
|
|
|
BSCP
6140
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
| $10.2K | ﹤0.01% |
+500
| New | +$10.1K |
2023 Q4
0 quarters
|
|
6141
CXApp
CXAI
$5.68M
| $10.2K | ﹤0.01% |
158
-99
| -39% | -$7.05K |
2023 Q1
3 quarters
|
|
6142
Ideal Power
IPWR
$65.2M
| $10.2K | ﹤0.01% |
1,310
+4
| +0.3% | +$34 |
2022 Q1
7 quarters
|
|
6143
Woori Financial
WF
$18B
| $10.2K | ﹤0.01% |
336
-432
| -56% | -$12.4K |
2015 Q4
32 quarters
|
|
6144
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$782M
| $10.2K | ﹤0.01% |
223
-62
| -22% | -$2.54K |
2023 Q3
1 quarter
|
|
|
SABA
6145
Saba Capital Income & Opportunities Fund II
SABA
$212M
| $10.1K | ﹤0.01% |
1,335
+868
| +186% | +$6.8K |
2023 Q3
1 quarter
|
|
6146
Invesco Large Cap Value ETF
PWV
$1.8B
| $10.1K | ﹤0.01% |
199
| – | – |
2021 Q4
8 quarters
|
|
6147
CALL
TechnipFMC
FTI
$27B
| $10.1K | ﹤0.01% |
500
-3,500
| -88% | -$71.7K |
2022 Q2
6 quarters
|
|
6148
Franklin FTSE United Kingdom ETF
FLGB
$841M
| $10K | ﹤0.01% |
399
-422
| -51% | -$10.2K |
2023 Q1
3 quarters
|
|
6149
FT Vest US Equity Deep Buffer ETF August
DAUG
$434M
| $10K | ﹤0.01% |
283
+183
| +183% | +$6.21K |
2022 Q4
4 quarters
|
|
|
CANO
6150
DELISTED
Cano Health, Inc.
CANO
| $10K | ﹤0.01% |
1,704
+137
| +9% | +$1.62K |
2021 Q4
8 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.